These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 58038)

  • 1. Defining the heterogeneity of anti-tumor antibody responses.
    Segal GP; Klinman NR
    J Immunol; 1976 Jun; 116(6):1539-46. PubMed ID: 58038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
    Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
    Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the idiotypic network in tumor immunity.
    Raychaudhuri S; Saeki Y; Chen JJ; Kohler H
    J Immunol; 1987 Dec; 139(11):3902-10. PubMed ID: 2824616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poorly metastatic tumor cell variants as primary targets of syngeneic antibody responses against murine melanoma.
    Parratto NP; Odebralski JM; Kimura AK
    Cancer Res; 1989 Jul; 49(14):3722-8. PubMed ID: 2736512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
    Chen PW; Kaba DS; Ananthaswamy HN
    Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations into the nature of Igh-V region-restricted T cell interactions by using antibodies to antigens on methylcholanthrene-induced sarcomas. I. Analysis of an Igh-V-restricted suppressor-inducer factor.
    Flood PM
    J Immunol; 1985 Mar; 134(3):1665-72. PubMed ID: 2578515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of the natural humoral anti-tumor immune response in mice as shown by monoclonal antibodies.
    Colnaghi MI; Menard S; Tagliabue E; Torre GD
    J Immunol; 1982 Jun; 128(6):2757-62. PubMed ID: 6896209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro antibody response to cell surface antigens. II. Monoclonal antibodies to human leukemia cells.
    Levy R; Dilley J
    J Immunol; 1977 Aug; 119(2):394-400. PubMed ID: 301891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
    Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones.
    Engers HD; Lahaye T; Sorenson GD; Glasebrook AL; Horvath C; Brunner KT
    J Immunol; 1984 Sep; 133(3):1664-70. PubMed ID: 6205090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
    J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo.
    Hostetler LW; Romerdahl CA; Kripke ML
    Cancer Res; 1989 Mar; 49(5):1207-13. PubMed ID: 2465081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent immunodominant and immunorecessive tumor-specific antigens on a malignant tumor: antigenic dissection with cytolytic T cell clones.
    Wortzel RD; Urban JL; Philipps C; Fitch FW; Schreiber H
    J Immunol; 1983 May; 130(5):2461-6. PubMed ID: 6187859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
    Kuroki M; Kuroki M; Koga Y; Matsuoka Y
    J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies.
    White J; Haskins KM; Marrack P; Kappler J
    J Immunol; 1983 Mar; 130(3):1033-7. PubMed ID: 6185566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syngeneic and allogeneic mouse lymphoma antisera: specificity, reaction with fetal antigen and protective capacity.
    Prager MD; Granatek CH; Ludden CM
    Isr J Med Sci; 1976; 12(4-5):325-33. PubMed ID: 939692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties.
    Goroff DK; Stall A; Mond JJ; Finkelman FD
    J Immunol; 1986 Apr; 136(7):2382-92. PubMed ID: 2419432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of anti-cancer antibodies from combinatorial libraries by whole-cell panning and stringent subtraction with human blood cells.
    Siva AC; Kirkland RE; Lin B; Maruyama T; McWhirter J; Yantiri-Wernimont F; Bowdish KS; Xin H
    J Immunol Methods; 2008 Jan; 330(1-2):109-19. PubMed ID: 18096183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiotypes on galactan binding myeloma proteins and anti-galactan antibodies in mice.
    Mushinski EB; Potter M
    J Immunol; 1977 Dec; 119(6):1888-93. PubMed ID: 72109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope-specific antibody feedback regulation of the humoral immune response against sheep erythrocytes in vitro: specific effects of anti-antigen antibody vs nonspecific T cell activities.
    Zubler RH
    J Immunol; 1981 Feb; 126(2):557-62. PubMed ID: 6161182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.